This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Prudential (PRU) Down 19.3% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Prudential (PRU) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Solid Q4 Earnings Boost Insurance ETFs
by Sweta Killa
The string of solid fourth-quarter earnings from the insurance industry players had a positive impact on the related ETFs that saw smooth trading over the past week.
Prudential (PRU) Q4 Earnings Surpass Estimates, Fall Y/Y
by Zacks Equity Research
Prudential's (PRU) Q4 results benefit from solid segmental contributions at Prudential Global Investment Management (PGIM), U.S. Individual Solutions and U.S. Workplace Solutions.
Prudential (PRU) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Prudential (PRU) delivered earnings and revenue surprises of 15.92% and 22.63%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Prudential Financial (PRU) Ahead of Earnings?
by Zacks Equity Research
Prudential Financial (PRU) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Prudential (PRU) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Prudential Financial's (PRU) Q4 performance is likely to have benefited from growth in asset-based businesses, solid international operations and pension risk transfer business.
Analysts Estimate Prudential (PRU) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Prudential (PRU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Prudential's (PRU) Unit Expands Travel Assistance Offerings
by Zacks Equity Research
Prudential's (PRU) arm chooses IMG to upgrade its travel assistance suite and a new insurance product.
Prudential (PRU) Down 1.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Prudential (PRU) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Should Value Investors Pick Prudential Financial (PRU) Stock?
by Zacks Equity Research
Let's see if Prudential Financial, Inc. (PRU) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Q3 Earnings Push Insurance ETFs Higher
by Sweta Killa
The Q3 earnings of insurance industry players had a positive impact on the related ETFs that saw smooth trading over the past month.
Prudential Financial (PRU) Q3 Earnings Top, Revenues Miss
by Zacks Equity Research
Prudential (PRU) Q3 earnings gain from decline in expenses and the effect of share buyback.
Prudential (PRU) Q3 Earnings Surpass Estimates
by Zacks Equity Research
Prudential (PRU) delivered earnings and revenue surprises of 4.55% and -9.42%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Prudential (PRU) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Prudential's (PRU) Q3 results are likely to benefit from growth in asset-based businesses, solid international operations and pension risk transfer business.
Prudential (PRU) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Prudential (PRU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Prudential Buys Assurance, Aids Financial Wellness Business
by Zacks Equity Research
Prudential Financial (PRU) closes Assurance IQ buyout to ramp up the financial wellness solutions business.
MetLife Suffers Due to Low Interest Rate, Eyes Recovery
by Zacks Equity Research
Low interest rates weigh on MetLife's (MET) investment income but various recovery measures help.
The Zacks Analyst Blog Highlights: Celgene, Sinopec, HSBC, Vertex Pharmaceuticals and Prudential Financial
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Celgene, Sinopec, HSBC, Vertex Pharmaceuticals and Prudential Financial
Top Stock Reports for Celgene, Sinopec & HSBC
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Celgene (CELG), Sinopec (SNP) and HSBC Holdings (HSBC).
Moving Average Crossover Alert: Prudential Financial
by Zacks Equity Research
Prudential Financial, Inc. (PRU) could be a stock to avoid from a technical perspective, as the firm is seeing unfavorable trends on the moving average crossover front.
Loews (L) Q2 Earnings Surpass Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Loews (L) Q2 results reflect higher earnings at CNA Financial and Boardwalk Pipeline.
Prudential (PRU) Q2 Earnings Miss Estimates, Revenues Top
by Zacks Equity Research
Prudential (PRU) Q2 earnings reflect solid performance at PGIM, U.S. Workplace Solutions and International Insurance, partly offset by weak U.S. Individual Solutions.
Prudential (PRU) Q2 Earnings Lag Estimates
by Zacks Equity Research
Prudential (PRU) delivered earnings and revenue surprises of -2.48% and 3.47%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Insurers Reporting Q2 Earnings on Jul 31: PRU, MET, WLTW, LNC
by Tanuka De
Insurers' Q2 earnings are likely to benefit from benign catastrophe environment, improved pricing and reinsurance agreements.
Prudential (PRU) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Prudential's (PRU) second-quarter results are likely to benefit from growth in asset-based businesses, improved margins in Group Insurance business and solid international operations.